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Abstract.  A monoclonal antibody (anti-ctsm-1)  recog- 
nizing exclusively a-smooth muscle actin was selected 
and characterized after immunization of BALB/c mice 
with the NH2-terminal  synthetic decapeptide of 
a-smooth muscle actin coupled to keyhole limpet 
hemocyanin. Anti-ctsm-1  helped in distinguishing 
smooth muscle cells from fibroblasts in mixed cultures 
such as rat dermal fibroblasts and chicken embryo 
fibroblasts.  In the aortic media, it recognized a 
hitherto unknown population of cells negative for 
a-smooth muscle actin and for desmin. In 5-d-old 
rats,  this population is about half of the medial cells 
and becomes only 8  +  5 % in 6-wk-old animals. In 
cultures of rat aortic media SMCs, there is a progres- 
sive increase of this cell population together with a 
progressive decrease in the number of a-smooth 
muscle actin-containing stress fibers per cell. Double 
immunofluorescent studies carried out with anti-ctsm-1 
and anti-desmin antibodies in several  organs revealed 
a heterogeneity of stromal cells. Desmin-negative, 
a-smooth muscle actin-positive cells were found in the 
rat intestinal muscularis mucosae and in the dermis 
around hair follicles. Moreover, desmin-positive, 
a-smooth muscle actin-negative cells were identified 
in the intestinal submucosa, rat testis interstitium, and 
uterine stroma, a-Smooth muscle actin was also 
found in myoepithelial cells of mammary and salivary 
glands, which are known to express cytokeratins. Fi- 
naUy, ~t-smooth muscle actin is present in stromal 
cells of mammary carcinomas, previously considered 
fibroblastic in nature. Thus, anti-asm-1 antibody 
appears to be a powerful probe in the study of smooth 
muscle differentiation in normal and pathological 
conditions. 
T  HOUGH actin is one of  the most conserved eukaryotic 
proteins, it is expressed in mammals and birds as six 
isoforms  characterized  by  two-dimensional  (2D)- 
PAGE and amino acid sequence analysis (14, 49, 56, 57, 59). 
Four of  them represent differentiation markers of muscle tis- 
sues and two are found practically in all cells (56, 57). Actin 
isoforms show >90% overall sequence homology, but only 
50-60%  homology in their 18 NH2-terminal residues  (56, 
57). The NH2-terminal region of actin appears to be a ma- 
jor antigenic region (2, 5, 34) and may be involved in the in- 
teraction of actin with other proteins such as myosin (31). 
Little is presently known about the function of actin iso- 
forms. It has been shown that the relative proportions of  actin 
isoforms are different in smooth muscles of different organs 
(12, 47;  Skalli,  O.,  J.  Vandekerckhove, and G.  Gabbiani, 
manuscript submitted for publication) and change within the 
same population  of smooth  muscle  cells  (SMCs) t during 
development (23, 24),  pathological  situations (11, 21), and 
different culture conditions (35, 46, 50). In noumuscle cells, 
a difference in the proportions of 13- and y-cytoplasmic actins 
has been reported between normal and tumoral T-lympho- 
1. Abbreviation  used in this paper:  SMC, smooth muscle cell. 
cytes (28). All these  studies have been performed  on cell 
populations by means of  2D-PAGE (14, 49, 59) or by analysis 
of the NH2-terminal peptides (56, 57) since, with possibly 
one exception (38), antibodies specific for a single actin iso- 
form are lacking. 
We have produced a monoclonal antibody against a syn- 
thetic decapeptide having the sequence of the NH2-terminal 
peptide of a-smooth muscle actin, which is specific for this 
isoform. We report here the characterization of  this antibody, 
the  identification  of an  a-smooth  muscle  actin-negative 
population among rat and human arterial SMCs and the lo- 
calization of a-smooth muscle actin in myoepithelial cells of 
mammary and salivary glands, as well as in stromal ceils of 
mammary carcinomas previously considered fibroblastic in 
nature. 
Materials and Methods 
Peptide Synthesis and Antibody Production 
The decapeptide was synthesized by classical solution technique (61) using 
various coupling procedures and a combination of acid-labile and hydro- 
genolytically cleavable protecting groups. The fully protected polypeptide 
Ac-Glu(OBut)-Glu(OBut)-Glu(OBut)-Asp(OBut)-Ser(But)-Thr(But)- Ala- 
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treatment and purified by hydrophobic interaction chromatography on a high- 
ly porous styrene-divinylbenzene copolymer. (Ac  =  acetyl [CHACO-]; 
Acm =  acetamidomethyl [CH3CONH-CH2-];  But =  tert-butyl [ether]; Et 
=  ethyl; OBut =  tert-butyl ester.) The acetaminomethyl group (Acre) was 
cleaved by exposure of the peptide to mercury(II)-acetate. The resulting 
peptide was homogeneous as judged by thin layer chromatography and ana- 
lytical HPLC and showed the expected amino acid composition upon amino 
acid analysis of a hydrolyzed sample. 
The peptide was coupled to BSA by the thiol function of its cysteine resi- 
due via a 3-maleimidopropionate moiety as anchoring group (20).  27 mg 
BSA was dissolved in 2 ml 0.1 M phosphate buffer, pH 7.5, and reacted with 
34  mg  N-succinimidyl-3-maleimidopropionate (dissolved in  0.3  ml  di- 
methylformamide). The reaction mixture was stirred for 25 min at pH 7.5 
before the pH was adjusted to pH 6.0 by addition of I  N HC1. The excess 
of reagent was removed by gel filtration on a Sephadex G-25S column, with 
0.05 M phosphate buffer,  pH 6.0, as eluent. The modified carrier protein 
was eluted in the first peak. This solution was reacled with 18.5 mg peptide 
for 20 h and again chromatographed on a  Sephadex G-25S, as described 
above.  The peptide-carrier conjugate was concentrated in an Amicon cell 
and dialyzed against 0.01 M phosphate buffer, pH 7.2, containing 0.145 M 
NaCI. The degree of substitution was 21  mol of peptide per tool BSA as 
determined by amino acid analysis (48). The peptide was coupled to keyhole 
limpet hemocyanin by the same procedure and a degree of substitution of 
415 mol of peptide per mol of hemocyanin was achieved. 
BALB/c mice (4-6 wk old) were immunized by intradermal and subcuta- 
neous injections of 50 gg of the hemocyanin-coupled peptide emulsified 
with an equal volume of Freund's complete adjuvant (final volume 200 lal). 
Two boosts of 50 ~tg of the same peptide conjugate emulsified with an equal 
volume of Freund's incomplete adjuvant (final  volume 200 lxl) were ad- 
ministered at 2-wk intervals. 3 d before fusion a mouse was injected intrave- 
nously with 50 I~g of the conjugate in 100 ~tl sterile PBS. On the fusion day, 
the mouse spleen was removed aseptically and leased in DME. The spleen 
cell suspension was fused with Sp 2/0 myeloma cells according to the pro- 
tocols of Galfre and Milstein (13) and De St. Groth and Scheidegger (7). 
Hybridoma cells were plated into five 96-weU micmtest plates (Falcon Lab- 
ware, Oxnard, CA) with liP peritoneal macrophages per well and grown 
for 2 wk in medium containing hypoxanthine/aminopterin/thymidine  (HAT) 
and 20%  fetal calf serum (FCS).  Anti-actin-secreting hybridomas were 
identified by solid-phase ELISA and immunofluorescence (see below). A 
clone secreting a-smooth muscle actin-speciflc  antibodies (anti-ctsm-1) was 
obtained after a precloning and two cionings by limiting dilution. The other 
bybridomas were transferred to a 24-well culture plate (Falcon Labware) and 
grown  to  confluence  before  being  frozen  in  hypoxanthine/thymidine 
medium containing 20%  FCS and 10% DMSO. 
ELISAs were performed on plates coated with either platelet (37) or bo- 
vine aortic (51) actin. Pure actin (0.5 ~tg in 50 lt150 mM bicarbonate buffer, 
pH 9.6) was added to each well of a polyvinylchloride microtiter plate (96 
wells; Dynatech Laboratories, Inc., Alexandria, VA) and allowed to adsorb 
overnight at 37°C. For screening, plates were rinsed with PBS and incubated 
for 1 h at 37°C with 40 I~1 of hybridoma supernatants. After three rinsings 
with  PBS, plates were incubated for  1 h  at  37°C  with 40  lal of rabbit 
anti-mouse IgG and IgM or rabbit anti-mouse IgG labeled with horseradish 
peroxidase (Nordic  Immunological  Laboratories,  Tilburg,  The  Nether- 
lands) diluted at 1:500 in PBS, containing 0.5% BSA and 0.05%  Tween 80. 
After three rinsings in PBS, plates were developed by adding 40 ~tl of a solu- 
tion of 5 mM 5-aminosalicytic acid plus 0.005 % H202.  Hybridoma super- 
natants positive for actin were further tested on cryostat sections of chicken 
gizzard (see below). 
Immunofluorescent Staining 
Double immunofluorescent staining with anti-asm-1 and various other anti- 
bodies was performed on 4-1xm-thick  cryostat sections, freshly isolated 
cells, and cell cultures as previously described (12, 46). Anti-ctsm-1 was 
used together with the following affinity-purified polyclonal antibodies: 
guinea pig anti-vimentin (22),  rabbit anti-desmin (22),  guinea pig anti- 
prekeratin (41), and rabbit anti-aortic smooth muscle myosin (3; Benzo- 
nana, G., O. SkaUi, and G. Gabbiani, manuscript in preparation). This last 
antibody is essentially similar to the anti-smooth muscle myosin antibody 
previously described by Larson et al. (26). In some instances, rabbit anti-rat 
Factor VIlI antibodies (gift of Dr.  G. Elemer, Department of Pathology, 
University of Lausanne, Lausanne, Switzerland) were also used. 
Tissue sections were fixed for 5 rain in acetone at -20"C and air dried. 
Cell cultures and cytospins were fixed for 5 min in methanol at -20°C. Di- 
lution of superuatants was done in PBS containing 3 mM EGTA in order 
to prevent the actin-depolymerizing activity present in serum (6). IgG con- 
centration of the supernatant was estimated after purification on protein 
A-Sepharose CL-4B (Pharmacia, Uppsala, Sweden). Anti-asm-1 was used 
constantly at an IgG concentration of 5 gg/ml. Affinity-purified  anti-vimen- 
tin, anti-desmin, anti-prekeratin, and anti-aortic smooth muscle myosin 
were used at a final IgG concentration of  0.85, 0.025, 0.20,  and 0.02 mg/ml, 
respectively.  As second antibodies, we used TRITC-labeled  goat anti- 
mouse IgG (Cappel Laboratories, Cochranville, PA) diluted 1:30, FITC-la- 
beled goat anti-rabbit IgG (Behringwerke, Marburg-Lahn, Federal Repub- 
lic of Germany), and FITC-labeled goat anti-guinea pig IgG diluted 1:20 
(Cappel Laboratories).  Cell counts were done independently by two re- 
searchers on 300 to 500 cells. Results are expressed as mean  5:  SEM. 
Photographs were taken with a  Zeiss photomicroscope equipped with 
epiillumination, using plan achromate  x40/1.0 or  x63/1.4 objectives, on 
3M 6401" color slide films (3M Co., Savona, Italy) or HP5 Ilford black and 
white film (llford Co., Basel, Switzerland). 
Immunoblotting Experiments 
Antibody specificity was determined by immunoblotting of monodimen- 
sional gels of whole tissue homogenates or purified actins and 2D-PAGE 
of actin isoforms. For SDS PAGE,  tissue samples were prepared as de- 
scribed previously (23) and electrophoresed on a 5-20% gradient gel (25). 
2D-PAGE separation of actin isoforms was done by isoelectric focusing 
using pH 4-6.5 ampholines (Pharmacia) followed by migration on a  10% 
SDS PAGE (32). To determine the actin isoforms recognized by anti-asm-1, 
gels were transferred to nitrocellulose papers (52) which were incubated 
with anti-asm-1 at an IgG concentration of 5 Ixg/ml in Tris-buffered saline 
containing 3% BSA and 0.1% Triton X-100, for 2 h at room temperature. 
After three rinsings in Tris-buffered saline, a second incubation was done 
with rabbit anti-mouse IgG labeled with horseradish peroxidase (Nordic 
Immunological Laboratories) diluted 1:1,000 in Tris-bulTered saline contain- 
ing 3% BSA and 0.1% Triton X-100 for 1 h at room temperature. 
We also controlled that aetin isoforms did transfer equally well to the 
nitrocellulose paper with a rabbit actin antibody recognizing all isoforms 
by ELISA. The nitrocellulose paper was first incubated with this antibody 
at a dilution of 1:10 and then with a goat anti-rabbit IgG labeled with horse- 
radish peroxidase (Nordic Immunological Laboratories) at a  dilution of 
1:500. Peroxidase activity was always revealed with 10 mM Tris-HCl, pH 
7.4, containing 0.025%  dianisidine and 0.0075%  H202. 
Tissue Culture 
SMCs were isolated from the thoracic aortic media of 5-d-old or 6-wk-old 
rats and from human thoracic aortic media by enzymatic digestion (21, 23, 
46). They were then cytocentrifuged at 125 g for 5 min with a Shandon cyto- 
centrifuge (Shandon Scientific Co., Ltd, London) and processed for inunu- 
nofluorescence. SMC cultures were prepared from the thoracic aorta of 
6-wk-old female Wistar rats by enzymatic digestion with collagenase and 
elastase as previously described (19) with minor modifications (46).  Im- 
munofluorescence was also done on primary and passaged aortic SMCs 
grown on glass coverslips (46). 
Rat fibroblasts were isolated from rat dermis after enzymatic digestion 
for 2 h at 37°C with DME containing 4 mg/ml collagenase (C. Histolyticum; 
Type I,  290  U/mg) (Sigma Chemical Co.,  St.  Louis,  MO),  0.5  mg/ml 
elastase (Pancreatopeptidase; Type III, 95 U/mg) (Sigma Chemical Co.), 
and  1 mg/ml soybean trypsin inhibitor (Boehringer Mannheim GmbH, 
Mannheim, Federal Republic of Germany). They were grown in DME con- 
taining 10% FCS. Multipassaged cells were plated on glass coverslips at a 
density of 3  x  liP cells/mi for 1 or 2 d before immunofluorescent staining. 
We examined also the following cell lines grown in DME containing 10% 
FCS and plated on glass coverslips: human embryo lung fibroblasts (gift of 
Dr. B. Azzarone, Institut National de la Sant6 et de la Recherche M&licale, 
Villejuif, France), chick embryo fibroblasts (gift of Dr. C. Meric, Depart- 
ment of Molecular Biology,  University of Geneva, Geneva, Switzerland), 
and BC3H1  cells (American Type Culture Collection, Rockville, MD), a 
cell line derived from vascular SMCs of a mouse brain tumor (50). 
Immunofluorescent Staining with Anti-asm-1 
of  Primary SMCs in the G1 or S-G2 Phase 
of the Cell Cycle 
According to autoradiographic experiments, the first DNA synthesis during 
primary culture of rat aortic SMCs takes place between 24 and 48 h after 
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SMCs entering for the first time in the S or G2 phase of the cell cycle from 
SMCs that remained in G1. Cells were labeled with the DNA binding dye 
Hoechst 33342 (gift of  Mr. P. Zaech, Swiss Institute for Experimental Can- 
cer Research, Lausanne, Switzerland), and G1 and S-G2 populations were 
sorted on the basis of their fluorescent intensity with an EPICS V  flow 
cytometer (Coulter Electronics Inc., Hialeah, FL), using an argon ion laser 
(Spectra-Physics Inc.,  Mountain View,  CA)  at  350-nm excitation wave- 
length as previously described (46). Aliquots of 2  x  104 sorted cells in the 
GI or S-G2 phases were immediately air dried on a glass slide, fixed, and 
processed for immunofluorescence as described above. 
Results 
Antibody Characterization 
Rabbit  immunization with  hemocyanin-coupled a-smooth 
muscle  NH2-terminal decapeptide resulted consistently in 
high titer antibodies staining SMCs, fibroblasts, and various 
epithelial cells, but not myocardial and striated muscle cells 
(data not shown). 
Hybridoma  supernatants  from  fusions  between  Sp2/0 
myeloma cells and lymphocytes from a mouse immunized 
with the a-smooth muscle NH2-terrninal peptide conjugate 
were first screened by ELISA against aortic or platelet actin. 
Eighty-one of 480 supernatants gave a positive reaction with 
one or both actins; 55 % of them were positive only for aortic 
actin and did also react on plates coated with the peptide used 
for immunization, but coupled to BSA. 
Previous work (47; Skalli, O., J. Vandekerckhove, and G. 
Gabbiani, manuscript submitted for publication) has shown 
that all mammalian smooth muscle tissues contain a-smooth 
muscle actin. To test the cross-reactivity of anti-asm-1 with 
"t-smooth muscle actin, we selected chicken gizzard which 
contain mainly ~/-smooth  muscle  actin  with  some  [I-non- 
muscle and 't-nonmuscle actins but not a-smooth muscle ac- 
tin (24, 39, 55). The primary sequence of "y-smooth muscle 
actin  from chicken gizzard and  from mammalian  smooth 
muscle have been shown to be identical (55). About 80% of 
the aortic actin-positive supernatants  stained vascular but 
not parenchymal SMCs in cryostat sections of chicken giz- 
zard. We cloned cells from one of these fusion wells, obtain- 
ing a clone secreting anti-asm-1, whose specificity was fur- 
ther  tested  by  immunoblotting  and  immunofluorescence. 
Anti-asm-l  was of the IgG class as determined by ELISA 
and immunofluorescence. 
Immunoblotting  on  SDS  PAGE  of total  extracts  from 
different tissues showed that the antibody reacts with aortic 
actin  but  not with  actin  from fibroblasts  (13- and  T-cyto- 
plasmic), striated muscle (a-sarcomeric), and myocardium 
(a-myocardial)  (Fig.  1  a).  Similar  results  were  obtained 
when  chicken gizzard,  platelets,  or  striated  muscle  were 
blotted after being loaded in amounts '~10-fold greater than 
aortic  actin,  using  IgG  concentrations  ranging  from  50 
ttg/ml to 0.1  0g/ml (Fig.  1 b). ELISAs gave similar results. 
Anti-asm-1 specificity was also assayed on blots of actin iso- 
forms separated by 2D-PAGE. We used human myometrium 
(Fig.  2,  a-c)  which  contains  a  slight  predominance  of 
a-smooth muscle actin, and human gastric muscle (Fig. 2, 
d-f)  which  contains  an  excess of "t-smooth muscle  over 
a-smooth muscle actin (Skalli, O., J.  Vandekerckhove, and 
G. Gabbiani, manuscript submitted for publication). In all 
cases, only the a-spot was recognized by anti-asm-1  (Fig. 
2, b  and e). We controlled that actin isoforms did transfer 
Figure 1. Immunoblotting with anti-asm-1 of  different tissue or cell 
total extracts (a) and of purified actins (b). (a) Coomassie Blue- 
stained 5-20 % gradient SDS PAGE  of rat aorta (lane 1), rat striated 
muscle (lane 2), rat myocardium (lane 3), and human fibroblasts 
(lane 4). Nitrocellulose sheet corresponding to SDS PAGE  after in- 
cubation with anti-asm-1  shows a positive reaction only with rat 
aorta actin (lane 5). (b) Coomassie Blue-stained 5-20% gradient 
SDS PAGE  of purified actins from bovine aorta (lane 1), chicken 
gizzard (lane 2), human platelets (lane 3), and rabbit striated mus- 
cle (lane 4), loaded in ~10-fold excess compared to bovine aortic 
actin. A positive reaction is seen only with bovine aortic actin. A, 
actin. 
equally well on the nitrocellulose filters by staining them 
with a rabbit anti-actin recognizing all isoforms (Fig. 2,  c 
and  f). Taken together, these results indicate that anti-asm-1 
reacts only with the a-smooth muscle isoform of actin within 
a broad range of concentrations and in the presence of an ex- 
cess of other actin isoforms. 
The specificity of anti-asm-1 was also tested by means of 
immunofluorescence on various tissues and cells (Fig. 3). As 
previously said, immunofluorescence on frozen sections of 
chicken gizzard with anti-asm-1 resulted in a strong positive 
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and  gastric  muscle  total  extracts.  (a  and  d)  Coomassie  Blue- 
stained 2D-PAGE of  human myometrium (a) and gastric muscle (d) 
shows the  separation  of actin  isoforms in three  spots (7-smooth 
muscle and "t-cytoplasmic actins co-migrate). (b and e) After incu- 
bation of the nitrocellulose paper with anti-asm-l, a single peroxi- 
dase positive spot is seen. (c and  f) When incubation of  the nitrocel- 
lulose paper is made with a rabbit antibody recognizing all actin 
isoforms, peroxidase activity is distributed in the three spots corre- 
sponding to those of the gel (a and d), showing that actin isoforms 
transfer equally well from the gel to the nitrocellulose paper. D, des- 
min;  I~, vimentin. 
stain  of blood  vessels  but  parenchymal  SMCs  remained 
negative within an IgG concentration range of 50 I~g/ml to 
0.1  lg/ml (Fig. 3 a). In rat intestine, SMCs of the outer lon- 
gitudinal  and  inner  circular  layers and  of the  muscularis 
mucosae were stained by anti-ams-1; epithelial cells, includ- 
ing brush borders, were not stained.  Fibroblasts in rat and 
human dermis,  as  well as  striated  muscle and myocardial 
cells (Fig. 3 c), were not stained by anti-asm-1. Anti-ctsm-1 
decorated stress fibers in cultured rat vascular SMCs and in 
a cell line containing a-smooth muscle actin, BC3H1 (50). 
In human embryo lung cells, a fibroblastic cell line, staining 
was always negative. However, in rat dermal fibroblast pri- 
mary cultures and, to a lesser extent, at the fourth passage, 
some cells showed stress fibers positive for a-smooth muscle 
actin, suggesting that primary and passaged rat dermis fibro- 
blasts contain  a  contaminant population  of SMCs  (Fig.  3 
e). In passaged cultures of chick embryo fibroblasts, stress 
fibers positive to anti-ctsm-1  were seen in  a  high propor- 
tion of cells, suggesting that this culture consists mainly of 
SMCs. 
Studies on Arterial SMCs 
Staining of rat or human aorta showed a positive reaction in 
Figure 3. Double immunofluorescent staining with anti-asm-I (a, 
c, and e) and anti-desmin (b and d) or anti-vimentin (f) on chicken 
gizzard (a and b), rat myocardium (c and d) and passaged rat der- 
mal fibroblasts (e and f). Anti-asm-1 stains only blood vessels on 
chicken gizzard (a) and rat myocardium (c), whereas chicken giz- 
zard parenchyrnal cells and cardiocytes are negative; anti-desmin 
antibodies stain blood vessels as well as chicken gizzard parenchy- 
mal cells (b) and cardiocytes (d). Note that in the chicken gizzard 
blood  vessel  more ceils  are stained  with  anti-asm-1  than  with 
anti-desmin  (a and b).  In passaged rat dermal fibroblasts, some 
cells show stress fibers stained with anti-asm-1 whereas others are 
negative for this antibody (e); all cells are positive for anti-vimentin 
which stains typically the intermediate filament network (f). Bar, 
10 gm. 
the media and in certain vasa vasorum but not in adventitia 
or endothelium (Fig. 4). Double immunofluorescent staining 
of  rat  and  human  aortic  media  with  anti-vimentin  and 
anti-asm-1 showed that both arteries contain an SMC popu- 
lation expressing vimentin, but not a-smooth muscle actin 
(Fig. 4).  Cytospins of enzymatically digested aortic media 
of 6-wk-old adult rats showed that this cell population consti- 
tutes 8 +  5% of aortic media SMCs. Isolated SMCs negative 
for a-smooth muscle actin were also negative for Factor VIII 
and desmin. The proportion of a-smooth muscle actin-nega- 
tive SMCs  varies during  development:  in  5-d-old rats,  as 
much as 49 +  3 % of  the cells of the aortic media are negative 
for a-smooth muscle actin, but positive for vimentin (Fig. 
5, a and b). Thus, differentiation of aortic SMCs takes place 
in the rat after birth as far as a-smooth muscle actin is con- 
cerned. When adult rat aortic SMCs are placed in culture in 
the presence of 10% FCS (46), the proportions of anti-asm-1 
strongly  stained  (more  than  four  positive  stress  fibers), 
weakly stained (between one and four positive stress fibers), 
and negative cells were as follows: 68 +  10%, 14 +  8%, and 
17 +  3 %, respectively, 5 d after plating, and then 26 +  3 %, 
48  +  1%, and 26  +  4%,  respectively, at the fifth passage 
(Fig. 5, c and d). This suggests that SMC growth in the pres- 
ence of 10% FCS is characterized by a gradual decrease of 
a-smooth  muscle  actin  in  cells  derived  from  replicating 
The Journal of Cell Biology, Volume  103, 1986  2790 Figure 4. Double immunofluorescence  with anti-asm-1 (a and c) and anti-vimentin  (b and d) on rat (a and b) and human (c and d) aorta. 
In the rat aorta,  endothelial cells (arrowheads) and adventitial fibroblasts are stained with anti-vimentin  (b) but not with anti-ctsm-I (a). 
Anti-ctsm-1 and anti-vimentin  stain medial SMCs of the rat and human media. However, few rat and human medial SMCs are stained 
with vimentin but not with anti-ctsm-l (arrows). Note that the staining pattern of anti-ctsm-I does not always fully correspond to that of 
anti-vimentin in cells which are stained by both antibodies.  Bar, l0 pm. 
Figure  5.  Double  immuno- 
fluorescence  with anti-ctsm-I 
(a and c) and anti-vimentin  (b 
and d) on cytospin of 5-d-old 
rat aortic medial SMCs (a and 
b) and nonconfluent primary 
culture of adult rat aortic me- 
dial  SMCs  (c  and d).  Both 
conditions  demonstrate  vi- 
mentin-positive,  anti-ctsm-1- 
negative  ceils  together  with 
vimentin-positive, anti-ctsm- 
1-positive SMC.  Stress  fibers 
are clearly seen in the  anti- 
asm-l-positive  SMCs  (c). 
Bar,  10 pm. 
Skalli et al. a-Smooth Muscle Actin Antibody  2791 Figure 6. Double immunofluorescent staining with anti-ctsm-1 (a, 
c, e, and g) and anti-desmin (b, d,f, and h) on rat intestine (a-d), 
rat testis (e and f), and rat uterus (g and h). In a and b, intestinal 
villi are cut transversally, while in c and d they are cut longitudi- 
nally. SMCs stained by anti-desmin and anti-etsm-1 are visible in 
the intestinal muscularis (a) and muscularis mucosae (a and c) and 
in small blood vessels of the testis interstitium (e and  f) and uterine 
stroma (g and h). The myoid cells surrounding seminiferous tubules 
are also positive for anti-~tsm-I (e) and anti--desmin (f).  Cells 
positive for anti-ctsm-1 and negative for anti-desmin are visible in 
the intestinal muscularis mucosae (arrows) (a). Cells positive for 
anti-desmin but not for anti-ctsm-1 (arrowheads) are visible in the 
muscularis mucosae (d), testis interstitium (f), and uterine stroma 
(h). E, epithelium. Bar, 10 gm. 
a-smooth muscle actin-positive SMC and only by a  rela- 
tively low level of replication of a-smooth muscle actin-neg- 
ative cells. 
We  investigated  further  whether  a-smooth  muscle  ac- 
tin-negative cells have  a  greater replicative activity  than 
other aortic medial SMCs when placed in culture in the pres- 
ence of 10% FCS. SMCs entering for the first time in S-G2 
phases  were  sorted by cytofluorimetry according to  their 
DNA  content.  After  double  immunofluorescent staining, 
the  percentage of cells positive  for vimentin  but  not  for 
a-smooth muscle actin was the same for cells in G1 and for 
those in S-G2 phase of the cell cycle, thus confirming that 
10%  FCS  does  not  stimulate  selectively  a-smooth  mus- 
cle-negative SMCs. 
Comparison of  Desmin and u-Smooth Muscle Actin 
Distribution in Cells of  Different Tissues 
Desmin is a widely accepted general marker of myogenic dif- 
ferentiation (33, 40); however, it is known that some vascular 
SMCs do not contain desmin (12, 42, 53). Thus, the presence 
of a-smooth muscle actin rather than the presence of desmin 
may represent a specific marker of SMCs (Skalli, O., J. Van- 
dekerckhove, and  G.  Gabbiani,  manuscript  submitted  for 
publication). We have verified in various normal tissues the 
distribution of a-smooth muscle actin and desmin by double 
immunofluorescent staining.  In the arterial wall of rat and 
man, desmin-positive cells appear always a-smooth muscle 
actin-positive, but the reverse is not true. When expressed 
as percentage of total cells, a-smooth muscle actin-positive 
and desmin-negative cells are 35  +  4% in 5-d-old rats and 
27  5- 6% in 6-wk-old rats. 
Cells positive for a-smooth muscle actin and negative for 
desmin are not found only in the aortic media, but also fo- 
cally in the muscularis mucosae of the rat intestine (Fig. 6, 
a and b) and around hair follicles of the rat dermis. Finally 
and surprisingly, cells containing desmin but not a-smooth 
muscle actin were found in rat intestinal submucosa (Fig. 6, 
c  and d),  testis  interstitiurn (Fig.  6,  e  and f)  and uterine 
stroma (Fig. 6, g and h) (observed in collaboration with Mr. 
T. Soldati, Department of Pathology, University of Geneva, 
Geneva,  Switzerland).  The desmin-positive,  a-actin-nega- 
tive cells of the testis are distinct from the classical myoid 
cells surrounding seminiferous tubules (4) which were posi- 
tive for both anti-desmin and anti-asm-1 (Fig. 6, e and f). 
Distribution of  a-Smooth Muscle Actin 
in Normal Mammary or Salivary Glands 
and in Breast Carcinomas 
Myoepithelial cells have been shown to express cytokeratin 
(8) and smooth muscle myosin (29). After immunofluores- 
cent staining of  human mammary gland and rat submaxillary 
gland with anti-asm-1, myoepithetial cells surrounding the 
acini and ducts were clearly positive (Fig. 7, a  and c). The 
staining of myoepithelial cells was  superimposable to that 
obtained with anti-smooth muscle myosin; in addition, as 
previously described (8), myoepithelial cells were decorated 
by prekeratin antibodies. Epithelial and stromal cells of the 
normal mammary and salivary glands were negative after 
immunofluorescent staining with anti-asm-1. 
The presence of a-actin in the rat submaxillary gland was 
further tested by immunoblots after 2D-PAGE (Fig. 8). Only 
the a-spot was recognized by anti-asm-1.  A similar result 
was  found  for  ductal  carcinoma  of the  breast  (data  not 
shown). 
Infiltrating ductal carcinoma of the breast is characterized 
by nests of tumor cells scattered in a dense, fibrous stroma. 
Stromal cells have been described as myofibroblasts (43, 54; 
for other references see 45).  Double immunofluorescence 
with  anti-prekeratin  and  anti-asm-1  showed that,  as  ex- 
pected,  tumor  cells  and  the  few  myoepithelial  cells  still 
present in tumor islets  were stained  with anti-prekeratin. 
Anti-asm-1 positively stained myoepithelial cells (Fig. 7 e); 
moreover, surprisingly, stromal cells were also positive after 
anti-asm-1  staining (Fig.  7  e),  unlike stromal ceils of the 
normal breast and typical myofibroblasts of human or ex- 
perimental wound granulation tissue (data not shown). Thus, 
in some fibrotic reactions, the main cellular components ap- 
pear to be SMCs. 
The Journal of Cell Biology, Volume  103, 1986  2792 Figure 7. Double immunofluorescent  staining  for a-smooth muscle actin (a, c, and e), smooth muscle myosin (b),  and prekeratin  (d and 
f) on rat submaxillary gland (a and b), human resting  mammary gland (c and d),  and infiltrating  duct carcinoma (e and f). In the rat 
submaxillar  gland, myoepithelial cells staining with anti-ctsm-I (a) and anti-aortic smooth muscle myosin (b) are superimposable; acini are 
not stained with both antibodies.  In the human resting mammary gland, myoepithelial cells brightly stained with anti-etsm-1  (c) are located 
around the prekeratin-positive,  anti-asm-l-negative ductal  epithelium  (d); no connective tissue  cells  are stained  with either antibody (c 
and d) with the exception  of a small blood vessel  stained  with anti-ttsm-1  (c).  In the infiltrating  ductal  carcinoma, some myoepithelial 
cells  positive  for a-smooth muscle actin and prekeratin  are present within  the typical keratin-positive,  anti-ctsm-l-negative, infiltrating 
tumoral cells (e and f).  Moreover,  numerous cells  of the stroma are positive  to anti-ctsm-I (arrows) (e).  Bar,  10 I.tm. 
Discussion 
Production of polyclonal or monoclonal antibodies  specific 
for a given actin isoform has been attempted using the follow- 
ing  various  approaches:  use  as  immunogen  of total  actin 
from chicken (16) or lower species (30, 44) and of an NH2- 
terminal  peptide  (5,  34);  or serial  affinity purifications  of 
polyclonal antibodies  (17, 36,  38).  All these methods have 
resulted  in the production of antibodies  directed against at 
least two isoforms with the possible exception of Roustan et 
al.  (38) who purified an antibody subpopulation specific for 
a-sarcomeric actin from a serum of a rabbit sensitized with 
skeletal muscle actin.  Some authors have not characterized 
the actin isoform(s) recognized by their antibodies obtained 
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with  anti-asm-1  of rat  sub- 
maxillary gland total extract. 
(a)  Coomassie  Blue-stained 
2D-PAGE of rat submaxillary 
gland  shows that  this  tissue 
contains  a  predominance  of 
I}-actin but also a- and "/-ac- 
tins. (b) After incubation  of  the 
nitrocellulose  paper with anti- 
asm-1, a single, small peroxi- 
dase-positive  spot  is  seen. 
When incubation of the nitro- 
cellulose paper is made with a 
rabbit  antibody  recognizing 
all actin isoforms, peroxidase 
activity  is  distributed  in  the 
three  spots corresponding to 
those of the gel (a),  showing 
that the  three  actin isoforms 
were transferred from the gel 
to the nitrocellulose paper. 
after  immunization  with  actin  and  selectively decorating 
SMCs (17). 
We  have  produced  a  monoclonal  antibody  against  the 
acetylated NH2-terminal decapeptide of a-smooth  muscle 
actin which reacts specifically with a-smooth muscle actin 
when  tested  by  means  of  immunoblotting,  ELISA,  and 
immunofluorescence. To our knowledge, the acetylation of 
the NH2-terminal residue is the only posttranslational mod- 
ification which  has  been described  in  this  location  (57). 
However, we cannot exclude that other possible posttransla- 
tional  modifications  of the  NH2-terminal peptide  are  not 
recognized by anti-asm-1. In any event, we have not noted 
discrepancies  between the distribution of anti-asm-1  im- 
munofluorescent staining and the presently known distribu- 
tion of a-actin by biochemical analysis. 
Raising polyclonal antibodies against a short peptide bear- 
ing amino acid sequences peculiar to a given protein isoform 
is a recognized method to produce antibodies against this iso- 
form. However, this method appears insufficient as far as ac- 
tin isoforms are concerned both from previous work (5, 34) 
and from our present experience with the immunization of 
rabbits  by  means  of  the  NH2-terminal  decapeptide  con- 
jugate of a-smooth muscle actin (see Results). Thus, produc- 
tion of monoclonal antibodies from mice hyperimmunized 
with NH2-terminal a-smooth muscle decapeptide conjugate 
appears  the most valid approach  in  order to achieve spe- 
cificity for a-smooth muscle actin and possibly other actin 
isoforms. However, even with this procedure, about half of 
the positive hybridoma supernatants  were not specific for 
a-smooth muscle actin, indicating that immunization of mice 
with the NH2-terminal decapeptide conjugate of a-smooth 
muscle actin resulted in at least two antibody populations: 
one specific for a-smooth muscle actin and the other cross- 
reacting with other actin  isoforms.  This suggests  that the 
NH2-terminal decapeptide of a-smooth muscle actin bears 
at least two epitopes: one shared by different actin isoforms, 
and the other specific for a-smooth muscle actin. We do not 
know  which  portion  of the  NH2-terminal  decapeptide of 
a-smooth muscle actin constitutes the epitope recognized by 
anti-asm-1. One m~. speculate that this epitope contains the 
sequence G~lu-A~sp-S~r-Tl~r  which differs from all the other 
actin isoforms. However, precise determination of this im- 
portant point requires further work such as that reported by 
Wehland et al. for an a-tubulin monoclonal antibody (58). 
Several studies (47, 56, 57; Skalli, O., J. Vandekerckhove, 
and G. Gabbiani, manuscript submitted for publication) have 
indicated  that  in  mammals,  SMCs  containing tissues  are 
characterized by the constant presence of a-, fl-, and y-actin 
isoforms in  various  proportions while fibroblastic tissues 
contain  only  13-  and  ~,-cytoplasmic isoforms.  Anti-asm-1 
may represent a good marker of smooth muscle differentia- 
tion  at  the  cellular  level  as  indicated  by  the  results  of 
immunofluorescent staining  of rat dermal  "fibroblasts" or 
chicken embryo "fibroblastsY  In  view of our results  (this 
work; Skalli, O., J. Vandekerckhove, and G. Gabbiani, manu- 
script submitted for publication), one should consider the 
possibility of revising the term ~ibroblastic" for cell lines 
containing a-smooth muscle actin (see for instance 27, 60). 
Anti-asm-1  stained blood vessels in rat striated muscle 
and in chicken gizzard; however, 2D-PAGE (see references 
24,  39 for chicken gizzard), analysis of the NH2-terminal 
peptides of actin (56, 57), and immunoblotting (our results) 
each failed to detect any a-smooth muscle actin in these tis- 
sues.  Additional expe  "rtments (not reported here) using rat 
aortic SMCs co-cultured with a human embryo lung fibro- 
blast line have shown that when the cell preparations have 
<5 %  a-smooth muscle actin-containing cells,  a  Coomas- 
sic  Blue-stained  2D-PAGE  showed  consistently no  a-ac- 
tin spot. All these results indicate that anti-asm-1 could be 
useful in the study of SMC development at the cellular level 
and in the identification of SMC tumors in surgical pathol- 
ogy specimens. Moreover, anti-asm-1 could be used in or- 
der to affinity purify a-smooth muscle actin. 
Immunofluorescent staining with anti-asm-1  has  shown 
that arterial SMCs in vivo and in vitro consist of three popu- 
lations as  far as their cytoskeletal features are concerned. 
One is vimentin, desmin, and a-smooth muscle actin posi- 
tive; the second is vimentin and a-smooth muscle actin posi- 
tive, but desmin negative; and the third is vimentin positive, 
but a-smooth muscle actin and desmin negative. We cannot 
exclude that this last cell population contains "f-smooth mus- 
cle actin;  however, our previous work on cytoskeletal fea- 
tures of aortic SMCs during development (23) and the pres- 
ent results after staining aortic SMCs of newborn and adult 
animals suggest that the arterial media of young, and to a 
lesser extent, adult rats and men contain a cellular population 
lacking the cytoskeletal markers of muscular differentiation. 
The role of  this population in repair and pathology of the vas- 
cular wall is not known. 
Previous studies have shown that replication of SMCs in 
vivo and  in  vitro  is  characterized by  a  decrease of their 
a-smooth  muscle actin content (35,  46).  The observation 
that SMCs in culture show a decrease of anti-asm-1 staining 
intensity rather than an  important increase of anti-asm-1- 
negative cells suggests that the decrease of a-smooth muscle 
actin content in  replicating SMCs  is due to a  diminished 
a-smooth muscle actin per cell rather than to a selection of 
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ported by the finding that after plating, anti-asm-1  negative 
SMCs  have  the  same  replicative  activity  as  anti-asm-1- 
positive SMCs. In any event, it appears that these a-smooth 
muscle  actin-  and  desmin-negative  SMCs  are  not  more 
stimulated to replicate in primary culture than other SMCs 
by the growth factors present in FCS. 
Cultured rat aortic SMCs have been studied by means of 
an actin antibody selected after fusion of myeloma cells with 
lymphocytes from a mouse immunized with chicken gizzard 
actin and reported to react with a- and ~,-smooth muscle ac- 
tins (16, 35).  In passaged cultures, unlike anti-asm-1,  this 
antibody did not stain SMCs (16).  We have no explanation 
for the discrepancy  between these results and the present 
findings. However, the constant presence in cultured SMCs 
of low but significant amounts of a-smooth muscle actin, of 
a-smooth muscle actin synthesis, and a-smooth muscle actin 
mRNA has been shown by several biochemical techniques (1, 
46). The same has been reported in SMC lines (9, 50). Our 
results after staining with anti-asm-1 confirm at the cellular 
level these previous analyses. 
The staining  of myoepithelial cells with anti-asm-1  raises 
the question of the origin of these peculiar cells. On the basis 
of staining  with prekeratin  antibodies, they have been pro- 
posed to be of epithelial origin in accordance to embryologi- 
cal data (8,  18). Whatever the answer, it appears  that myo- 
epithelial cells contain both epithelial and mesenchymal dif- 
ferentiation markers.  Thus,  cytoskeletal features,  although 
powerful  indicators,  may  not  always  represent  absolute 
markers  of cellular origin. 
Staining  with anti-asm-1 may help in the characterization 
of stromal cell heterogeneity  in various organs.  Thus,  we 
know  now  that  a-smooth  muscle  actin-positive,  desmin- 
negative  SMCs  are  present  in  the  intestinal  muscularis 
mucosae and around hair follicles, in addition to those well 
characterized in the vascular wall (12, 42, 53). Moreover, a 
desmin-positive,  a-smooth  muscle  actin-negative  popula- 
tion of stromal cells has been identified in the stroma of in- 
testine,  testis,  and uterus.  We cannot exclude that this cell 
population contains "y-smooth muscle actin or that the NH2- 
terminal decapeptide of a-smooth muscle actin is occluded 
and  thus  cannot  be  recognized  by  anti-asm-1.  This  is  a 
general restriction to the use of any monoclonal antibody, but 
so far when a-actin was found by biochemical means, it was 
also detected by  immunofluorescence with anti-asm-1.  In 
any  event,  the  functional  significance  of  these  desmin- 
positive,  a-actin-negative  cells is presently unknown. 
Finally,  the finding that stromal cells of mammary carci- 
noma contain a-smooth muscle actin may throw some new 
light on the pathophysiological mechanisms  of fibrotic re- 
actions. The observation that during wound healing and fi- 
brocontractive diseases fibroblast modulate into a cell type 
possessing contractile features, called the myofibroblast  (10; 
for review see 45), has allowed a better understanding  of the 
mechanisms  of connective  tissue  retraction.  The  present 
finding, that during a well-established fibrotic stromal reac- 
tion the cells involved show smooth muscle properties, may 
define a new category of fibrotic reactions among fibroma- 
toses, a complex group of pathological changes showing fea- 
tures of inflammatory and tumoral lesions (43, 45, 54). It has 
been reported that mammary carcinoma cells produce one 
or more factors stimulating the replication of stromal fibro- 
blasts (15). Our findings suggest that this or these factor(s) 
are  also capable of stimulating smooth muscle differenti- 
ation. 
In conclusion, anti-asm-1  appears to represent a useful 
tool for the study of smooth muscle differentiation and char- 
acterization in normal and pathological conditions. 
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